Search results for "lesion"

showing 10 items of 1094 documents

Antibacterial and white spot lesions preventive effect of an orthodontic resin modified with silver-nanoparticles

2021

Background To evaluate the antibacterial property of a modified orthodontic resin with different concentrations of silver-nanoparticles (AgNPs), and quantify its preventive effect on the formation of white spot lesions (WSLs). Material and Methods An orthodontic resin (Transbond XT) was modified with four concentrations of AgNPs (1%, 0.5%, 0.1%, and 0.05%), the orthodontic resin without AgNPs was used as control. Polymerized resin discs (n=80) were submitted to Agar diffusion test on Petri dishes inoculated with Streptococcus mutans and Lactobacillus acidophilus. In addition, resin discs of each group (n=40) were placed in 96-well plates with bacterial suspensions to evaluate the colony-for…

Antibacterial propertyadhesivebiologybusiness.industryChemistryResearchDentistryOrthodonticsWhite spot lesionsResin modifiedbiology.organism_classificationStreptococcus mutansSilver nanoparticleantibacterialLactobacillus acidophilusSilver-nanoparticlesTransbond XTAgar diffusion testorthodonticsbusinessAntibacterial activityGeneral DentistryUNESCO:CIENCIAS MÉDICAS
researchProduct

Effect of an orthodontic resin modified with silver-nanoparticles on enamel color change

2021

Background: To evaluate the effect of an orthodontic resin modified with various concentrations of silver-nanoparticles (AgNPs) on enamel color. Material and Methods: Twenty lower premolars were collected and divided into four groups (n = 5) according to the concentration of AgNPs (0.05%, 0.1%, 0.5%, and 1% wt/wt). Additionally, a group bonded with a conventional resin was used as control (n=5). Previous to the bracket bonding, enamel color was measuring with a spectrophotometer. Specimens were stored for 6 months in deionized water. Brackets were debonded and color changes of enamel were calculated with the CIEDE 2000 formula (ΔE00). One-way ANOVA and Tukey test were used to assess the col…

Antibacterialstomatognathic systemSilver-nanoparticlesAdhesiveOrthodonticsWhite spot lesionsGeneral DentistryUNESCO:CIENCIAS MÉDICAS
researchProduct

mHealth for the Monitoring of Brace Compliance and Wellbeing in Adolescents with Idiopathic Scoliosis: Study Protocol for a Feasibility Study

2021

Escoliosis idiopática del adolescente; Aplicación móvil; Eficacia del tratamiento Escoliosi idiopàtica de l'adolescent; Aplicació mòbil; Eficàcia del tractament Adolescent idiopathic scoliosis; Mobile application; Treatment effectiveness Attempts to optimize monitoring of brace adherence prescribed to adolescents with idiopathic scoliosis (IS) have generally relied on sensors. Sensors, however, are intrusive and do not allow the assessment of psychological and physical consequences of brace use that might underlie poor adherence. Mobile applications have emerged as alternatives to monitor brace compliance. However, the feasibility and utility of these app-based systems to assess key psychol…

Aparells ortopèdicsFerides i lesions TractamentHealth Toxicology and Mutagenesis:Health Services Administration::Patient Care Management::Delivery of Health Care::Telemedicine [HEALTH CARE]Adolescents0302 clinical medicineMedicine030212 general & internal medicinemHealthEscoliosiRbrace adherenceTelemedicinaInformation and Communication TechnologiesTelemedicineTest (assessment)DistressScoliosistreatment effectiveness:Musculoskeletal Diseases::Bone Diseases::Spinal Diseases::Spinal Curvatures::Scoliosis [DISEASES]adolescent idiopathic scoliosisMedicinemusculoskeletal diseasesmedicine.medical_specialtyAdolescentTelefonia mòbilArticle:administración de los servicios de salud::gestión de la atención al paciente::prestación sanitaria::telemedicina [ATENCIÓN DE SALUD]03 medical and health sciencesQuality of life (healthcare)HumansComunicació i tecnologiaProtocol (science)adolescent idiopathic scoliosis; Information and Communication Technologies; mobile application; brace adherence; treatment effectivenessBracesbusiness.industry:enfermedades musculoesqueléticas::enfermedades óseas::enfermedades de la columna vertebral::desviaciones de la columna vertebral::escoliosis [ENFERMEDADES]:equipos y suministros::equipo quirúrgico::equipos ortopédicos::aparatos ortésicos::tirantes [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]Public Health Environmental and Occupational HealthUsabilitymobile applicationBraceMood:Equipment and Supplies::Surgical Equipment::Orthopedic Equipment::Orthotic Devices::Braces [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]Physical therapyQuality of LifeFeasibility StudiesPatient Compliancebusiness030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?

2005

Objective—Human C-reactive protein (CRP) was reported to accelerate atherosclerotic lesion development in male but not in female apolipoprotein E (apoE) knockout mice. Here, mice expressing rabbit CRP (rbCRP) were crossbred onto apoE knockout animals, and the effect on atherogenesis was studied.Methods and Results—Hemolytic complement activity could not be detected in apoE knockout mice. Furthermore, in contrast to human complement, neither rabbit nor human CRP complexed to modified low-density lipoprotein–activated murine complement. At 52 weeks, rbCRP levels were similar in male and female transgenic animals. Serum cholesterol levels were equivalent in female animals irrespective of rbCRP…

Apolipoprotein EMalemedicine.medical_specialtyPathologyRatónTransgeneHypercholesterolemiaMice TransgenicLesionMiceApolipoproteins ESpecies SpecificityInternal medicinemedicineAnimalsHumansTransgenesAortaMice KnockoutbiologyVascular diseaseC-reactive proteinCholesterol LDLComplement System Proteinsmedicine.diseaseAtherosclerosisComplement systemMice Inbred C57BLDisease Models AnimalEndocrinologyC-Reactive ProteinKnockout mousebiology.proteinFemaleDietary ProteinsRabbitsmedicine.symptomCardiology and Cardiovascular MedicineArteriosclerosis, thrombosis, and vascular biology
researchProduct

TP53 codon 72 polymorphism and cervical cancer

2009

Background Cervical cancer is caused primarily by human papillomaviruses (HPV). The polymorphism rs1042522 at codon 72 of the TP53 tumour-suppressor gene has been investigated as a genetic cofactor. More than 80 studies were done between 1998 and 2006, after it was initially reported that women who are homozygous for the arginine allele had a risk for cervical cancer seven times higher than women who were heterozygous for the allele. However, results have been inconsistent. Here we analyse pooled data from 49 studies to determine whether there is an association between TP53 codon 72 polymorphism and cervical cancer.Methods Individual data on 7946 cases and 7888 controls from 49 different st…

ArginineMESH : Polymorphism GeneticMESH: Genes p53MESH : AgedPhysiologyUterine Cervical NeoplasmsMESH: Papillomavirus Infections[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineGenotypeMESH : FemaleCervical cancerGeneticsMESH: AgedMESH : Papillomavirus Infections0303 health sciencesMESH: Middle AgedHPV infectionMESH: Genetic Predisposition to DiseaseMiddle AgedMESH : AdultWILD-TYPE P53Hardy–Weinberg principle3. Good healthMESH: Uterine Cervical NeoplasmsOncologyMESH: Young Adult030220 oncology & carcinogenesisMeta-analysisFemaleAdultAdolescentMESH : Uterine Cervical NeoplasmsMESH : Young Adult[SDV.CAN]Life Sciences [q-bio]/CancerMESH : Genes p5303 medical and health sciencesYoung AdultSQUAMOUS INTRAEPITHELIAL LESIONSMESH : AdolescentINDIAN WOMENMESH: Polymorphism GeneticmedicineHumansGenetic Predisposition to DiseaseMESH : Middle AgedAllele030304 developmental biologyAgedMESH: AdolescentMESH: HumansPolymorphism GeneticHUMAN-PAPILLOMAVIRUS TYPE-16business.industryP53 ARG72PRO POLYMORPHISMHEALTHY WOMENPapillomavirus InfectionsMESH : HumansMESH: AdultOdds ratiomedicine.diseaseGenes p53GENOTYPESHARDY-WEINBERG EQUILIBRIUMRISK-FACTORSMESH : Genetic Predisposition to DiseasebusinessMESH: FemaleHPV INFECTIONLancet Oncology
researchProduct

Myopathic form of arthrogryposis and microcirculation lesion.

1989

A microvascular lesion characterized by extensive platelet aggregation, thrombosis, vascular damage with hemorrhages was found in the muscle of a 2-month-old boy with a myopathic form of the arthrogryposis syndrome. The lesion morphologically resembled the vascular leakage seen in immunologically mediated tissue injury. A degradative effect of proteases released during platelet and neutrophil aggregation on the muscle and joints is suggested.

ArthrogryposisArthrogryposisMalePathologymedicine.medical_specialtyVascular diseasebusiness.industryMusclesInfantAnatomyBlood Coagulation Disordersmedicine.diseaseThrombosisPathophysiologyMicrocirculationLesionNeurologyMuscular DiseasesmedicineHumansPlateletNeurology (clinical)medicine.symptombusinessNeutrophil aggregationJournal of the neurological sciences
researchProduct

An Artificial Neural Network for 3D Localization of Brainstem Functional Lesions

2002

The human brainstem is a highly complex structure where even small lesions can give rise to a variety of symptoms and signs. Localizing the area of dysfunction within the brainstem is often a difficult task.To make localization easier, we have developed a neural net system, which uses 72 clinical and neurophysiological data inputs and displays it (using 5268 voxels) on a three-dimensional model of the human brainstem. The net was trained by means of a back-propagation algorithm, over a pool of 580 example-cases. Assessed on 200 test-cases, the net correctly localized 83.6% of the target voxels; furthermore the net correctly localized the lesion in 31/37 patients. Because our computer-assist…

Artificial neural networkComputer scienceSpatial errorNeurophysiologyBrainstem lesioncomputer.software_genreLesionVoxelmedicineBrainstemmedicine.symptomNeurosciencecomputer3d localization
researchProduct

High-frequency rotational ablation following failed percutaneous transluminal coronary angioplasty.

1994

Percutaneous transluminal coronary angioplasty (PTCA) failed in 29 of 1,150 patients (2.5%) after successful passage of the guide wire. The reasons for failure were inability to pass the lesion with a balloon in 28 patients and inability to dilate the lesion in 1 patient. In these patients (15 stenoses and 14 chronic occlusions) rotational ablation was performed. We were able to pass the burr through the lesion in all of them, resulting in a reduction of diameter stenosis from 87 +/- 15 to 51 +/- 18%. Rotational ablation alone was initially successful (stenoses reduction > 20% and residual stenoses < 50%) in 15 of 29 (52%) patients. Additional PTCA was performed in 21 of 29 (72%) patients, …

Atherectomy CoronaryMalemedicine.medical_specialtyPercutaneous transluminal coronary angioplastyRotational ablationCoronary Artery DiseaseBalloonCoronary AngiographyLesionRecurrenceInternal medicinemedicineHumansMajor complicationTreatment FailureAngioplasty Balloon Coronarybusiness.industryMiddle AgedCoronary heart diseaseSurgeryDiameter stenosisCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessCatheterization and cardiovascular diagnosis
researchProduct

Photobleaching measurements of pigmented and vascular skin lesions: results of a clinical trial

2011

The autofluorescence photobleaching intensity dynamics of in vivo skin and skin pathologies under continuous 532 nm laser irradiation have been studied. Overall the 141 human skin malformations were investigated by laser induced skin autofluorescence photobleaching analysis. Details of equipment are described along with some measurement results illustrating potentiality of the technology.

AutofluorescencePathologymedicine.medical_specialtyintegumentary systemIn vivobusiness.industryMedicineHuman skinSkin autofluorescencePigmented skinbusinessSkin lesionPhotobleachingSPIE Proceedings
researchProduct

Cutaneous Lupus Erythematosus

2008

Lupus erythematosus (LE) is an inflammatory autoimmune disease, characterized by a heterogeneous clinical presentation. The skin lesions are one of the most frequent symptoms of the disease and present with a broad spectrum of LE-nonspecific and LE-specific cutaneous manifestations. Therefore, the development of a classification for skin lesions in the disease has proven difficult. For example, the LE-nonspecific cutaneous manifestations include livedo racemosa, thrombophlebitis, and leukocytoclastic vasculitis and can be associated with high disease activity and systemic organ involvement. The LE-specific cutaneous manifestations encompass the subtypes of cutaneous lupus erythematosus (CLE…

Autoimmune diseasemedicine.medical_specialtyLupus erythematosusmedicine.diagnostic_testbusiness.industryfungiDiseaseLivedo racemosamedicine.diseaseThrombophlebitisDermatologySkin biopsyPhototestingmedicineCutaneous Lupus ErythematosusAntimalarial Agentmedicine.symptombusinessPanniculitisSkin lesionTherapeutic strategyAnti-SSA/Ro autoantibodies
researchProduct